Activin enhances skin tumourigenesis and malignant progression by inducing a pro-tumourigenic immune cell response.
Fiche du document
2011
- doi: 10.1038/ncomms1585
- issn: 2041-1723
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.1038/ncomms1585
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/22146395
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/eissn/2041-1723
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_196C9DD1F0446
info:eu-repo/semantics/openAccess , Copying allowed only for non-profit organizations , https://serval.unil.ch/disclaimer
Sujets proches
Integument (Skin) CutisCiter ce document
M. Antsiferova et al., « Activin enhances skin tumourigenesis and malignant progression by inducing a pro-tumourigenic immune cell response. », Serveur académique Lausannois, ID : 10.1038/ncomms1585
Métriques
Partage / Export
Résumé
Activin is an important orchestrator of wound repair, but its potential role in skin carcinogenesis has not been addressed. Here we show using different types of genetically modified mice that enhanced levels of activin in the skin promote skin tumour formation and their malignant progression through induction of a pro-tumourigenic microenvironment. This includes accumulation of tumour-promoting Langerhans cells and regulatory T cells in the epidermis. Furthermore, activin inhibits proliferation of tumour-suppressive epidermal γδ T cells, resulting in their progressive loss during tumour promotion. An increase in activin expression was also found in human cutaneous basal and squamous cell carcinomas when compared with control tissue. These findings highlight the parallels between wound healing and cancer, and suggest inhibition of activin action as a promising strategy for the treatment of cancers overexpressing this factor.